In this work, micellar electrokinetic chromatographic method was developed and optimized for the determination of hydrochlorothiazide (HCT) in the presence of irbesartan (IRB), bisoprolol (BISO) and HCT main impurity. Four factors affecting the separation-sodium dodecyl sulphate (SDS) concentration, buffer concentration, temperature and voltage-were studied. Optimization studies were performed with the aid of a central composite design with six central points. The optimal separation conditions were obtained by applying Derringer's desirability function, and the conditions were borate buffer 17 mM ( pH = 9), SDS 5.2 mM, temperature 25°C and voltage 12 kV. HCT, IRB and BISO were successfully determined in their pure form and pharmaceutical formulations with separation in <8 min. Calibration curves (R > 0.999) were prepared and complete method validation was performed according to ICH guidelines. The results obtained were statistically compared with that of the official methods.
Introduction
Hydrochlorothiazide (HCT) or 6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4 benzothiadiazine-7-sulfonamide is a diuretic drug of the thiazide class that acts by inhibiting kidneys' ability to retain water and is frequently used for the treatment of hypertension. Irbesartan (IRB) or 2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro [4.4] non-1-en-4-one is an angiotensin II receptor antagonist and mainly used for the treatment of hypertension. Bisoprolol (BISO), chemically designated as 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl) phenoxy]propan-2-ol (1). According to British Pharmacopoeia (BP), chlorothiazide or 6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide is considered as the main impurity (1) and the degradation product of HCT (HCT impurity), and the molecular structure is shown in Figure 1 .
HCT is commonly coformulated with IRB and BISO; few methods have been reported for the simultaneous determination of HCT and IRB in their pharmaceutical formulations, such as HPLC (2-9), spectrophotometry (2-13) and electrophoresis (14) . Different analytical methods have been reported for the determination of HCT and BISO, which include HPLC (15) (16) (17) (18) (19) (20) and spectrophotometry (15, 21, 22) . HCT was determined using micellar electrokinetic chromatography (MEKC) along with aliskiren (23) and with olmesartan and amlodipine (24) , while there are no reported methods for the simultaneous determination of the HCT, IRB and BISO in the presence of structurally related HCT impurity.
MEKC is considered as one of the most popular and flexible techniques of capillary electrophoresis (CE) offering the greatest selectivity to the widest range of compounds and can be considered as the separation method of choice when performing CE analysis of pharmaceutical substances. It uses an ionic micellar solution instead of a simple buffer. The most commonly used surfactant is sodium dodecyl sulfate (SDS), an ionic surfactant. The anionic SDS micelles are electrostatically attracted toward the anode (25) (26) (27) .
The problem of MKEC is that many variables need to be optimized such as surfactant concentration, buffer concentration, temperature and voltage. Varying these parameters generates a vast amount of data. Analysis and interpretation of such large datasets is very difficult unless using chemometrics. Using experimental designs help in interpretation of relationships between different variables and considered time saving. Different chemometric approaches were reported for optimization of experiments as overlapping resolution maps (28), factorial design (29) and response surface (RS) methodology (30) . The RS experimental design offers the possibility of investigating a high number of variables at different levels with a limited number of experiments. Since the MEKC method has to be applied for the pharmaceutical analysis, optimization of multiple responses (analysis time and resolution) is needed. To achieve optimization of multiple responses, Derringer's desirability function (multicriteria decisionmaking tool) (31) as a chemometric protocol has been applied (32) (33) (34) . Its main advantage is the simultaneous optimization of important factors and multiple responses, which enables the prediction of chromatographic retention and postulation of optimum conditions for separation. So, our work was targeted to the application of MEKC separation using a multiresponse chemometric protocol to achieve best separation and determination of HCT in the presence of very closely related impurity or degradation product (HCT impurity), and simultaneous determination of HCT coformulated antihypertensive drugs: IRB and BISO.
Experimental

Chemicals and reagents
HCT and IRB working standards were kindly donated by October Pharm, Cairo, Egypt. BISO working standard was kindly donated by Amoun Pharmaceutical Co., Cairo, Egypt, and the percentage purity was found to be 99.83, 100. 28 
Instrumentation
The study was performed using an Agilent 7100 capillary electrophoresis instrument equipped with a photodiode array detector. Data acquisition was done by means of an Agilent ChemStation for CE system.
Preparation of borate buffer and SDS solutions
Borate buffer 25 mM ( pH = 9) was prepared by dissolving 0.238 g of borax in 100 mL of deionized water (1). SDS 5 mM was prepared by dissolving 0.003 g of SDS in 100 mL of deionized water.
Preparation of standard solutions
Stock standard solution of each of HCT, IRB, BISO and HCT impurities (1 mg/mL) was prepared by accurately weighing and dissolving 100 mg of pure drug in methanol and then diluting to volume in 100-mL measuring flasks. An aliquot of 10 mL of each of the prepared stock standard solutions was further diluted with methanol to a final volume of 100 mL. The diluted solutions were used as working standard solutions with a concentration of 100 µg/mL for HCT, IRB and BISO.
Preparation of sample solutions
Twenty tablets each of Kansartan Plus ® and Lodoz ® tablets were accurately taken (after the removal of the coat with methanol) and were finely powdered. An accurate weight of each of the powdered tablets was transferred into separate 100-mL volumetric flasks, completed to the mark with methanol and sonicated for 10 min. The solution was then filtered into a 100-mL volumetric flask. The proposed method was applied for the analysis of the pharmaceutical formulations and the concentrations of the cited drugs were calculated.
Experimental design
Trial MEKC experiments indicated that four factors, such as molarity of SDS and buffer solutions, voltage and temperature, were the main factors that affected both retention time and resolution of the separated peaks. Therefore, a central composite-RS design (CCD-RS) was used to examine the influence of these four factors on the resolution (Rs1 and Rs2) and run time. Trial experiments were conducted to select the range for each factor. The ranges of the variables were as follows: molarity of SDS (A), 4. Table I .
Results
Multiresponse optimization
The variables presented in Table I were chosen based on our preliminary experiments. The results concerning the tested variables on the resolution (Rs1 and Rs2) and the analysis time were considered. Where, Rs1 is the resolution between HCT and HCT impurity, and Rs2 is the resolution between IRB and HCT. The three response values ranged from 0.95 to 4.39, 1.19 to 7.24 and 13.8 to 25.6 min for Rs1, Rs2 and analysis time, respectively. A design matrix was generated between factors and responses by RS regression analysis. Analysis of variance (ANOVA) was generated for reduced surface-designed models, the obtained P values were <0.05 and the coefficients of the reduced models are presented in Table II . The signal-to-noise ratio was in the range of 10-37. The coefficient of variation (% CV) was found to be <10%. Box-Cox plots are shown in Figure 2 , and the current power transformation for each response falls closest to the best λ value and within the confidence interval. Figures 3-5 show the interaction of the studied factors on the resolution and analysis time.
Derringer desirability function
By applying Derringer desirability function, the criteria for optimization of each individual response are shown in Figure 6 . A high 
Validation
Good correlations were obtained between the peak area and concentration in the range of 5.00-100.00 µg/mL for both HCT and IRB and 10.00-100.00 µg/mL for BISO, with a correlation coefficient of >0.999. LOD and LOQ were calculated (Table III) . The accuracy of the proposed method was assessed using different concentrations of each drug and found to be 100.36 ± 1.97, 100.24 ± 1.47 and Rs1 and Rs2 are the resolution between the separated peaks of HCT impurity, HCT and BISO. 
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99.20 ± 2.03 for HCT, IRB and BISO, respectively. Multiple injections of standard substances were performed and the obtained RSD% was found to be <2% for each drug. Precision was performed by injecting three different concentrations of each drug, at least three times a day and on different days; good RSD% values were obtained as shown in Table III . Results obtained by the determination of the amount of HCT and IRB in Kansartan Plus ® tablets and HCT and BISO in Lodoz ® tablets are shown in Table IV . To assess the accuracy of the method for the determination of the studied drugs in the sample matrices, injection of placebo was done; it was observed that there is no interference of the placebo with principal peaks.
Statistical comparison
The results obtained by the developed method were statistically compared with that obtained by the official method (1) for the determination of the studied drugs in their pure forms, which are presented in Table V . 
Discussion
MEKC is usually applied in simultaneous separation of complex mixtures of pharmaceutical substances with very similar structural and physicochemical characteristics. Also it can be used for the separation of structurally related impurities from the main active drug as they will possess similar structure and physicochemical properties to the main drug that makes their separation a challenging task (25) . So, in this work, the MEKC method was developed and optimized using a chemometric protocol for the separation of HCT from its major impurity and other coformulated antihypertensive drugs: IRB and BISO. For optimization of the experimental conditions, CCD-RS was applied. Upon applying the experiments, the order of separated peaks was BISO, HCT impurity, HCT and IRB. BISO shows good separation from the other peaks. The results concerning the tested variables on the resolution (Rs1 and Rs2) and the analysis time were considered. Where, Rs1 and Rs2 are the calculated resolution between HCT-HCT impurity and IRB-HCT, respectively.
A design matrix was generated between factors and responses by RS regression analysis. ANOVA was generated for reduced surface designed models, which exhibited that curvature is significant for the three factors studied. Since values are <0.05, the reduced quadratic model was advised. Model terms with values >0.05 were eliminated by backward elimination to achieve more realistic models (35) . In the present study, the predicted and adjusted R values for each response were in a good agreement (36) , which revealed that the experimental data are in good fit with the second-order polynomial equations. All the reduced model values <0.05 implies their significance, and all models having a non-significant lack of fit indicate a good model.
The value of signal-to-noise ratio was >4, showing (37) adequate model discrimination. The % CV was <10%, indicating the good reproducibility of the developed models. Box-Cox plots were used as a tool to determine the most appropriate power transformation to be applied to the response data, and these transformations were none, natural log and inverse square root for Rs1, Rs2 and analysis time, respectively. As shown in Figures 3 and 4 , the positive interaction of A, B, C and D is statistically important for both resolution and analysis time. Altering the factors A, C and D, low to high levels, decreases Rs1 values, while for B alteration from low to high increases Rs1. For Rs2, altering the factors B, C and D, low to high levels, decreases Rs1 values, while for A alteration from low to high increases Rs2. Altering the factors D, C and A, low to high levels, powerfully affect (decreasing order) the analysis time, and it only increase with high levels of B. The interaction graphs, Figure 5 , appear with nonparallel lines indicating the positive interaction between the significant factors on the resolution and analysis time.
Derringer's desirability function was used to multiresponse global optimization (38) . Desirability function can take values from 0 to 1. Weights can vary from 0.1 to 10. Weights lower than 1 give less importance to the goal, whereas weights >1 give more importance to the goal. In the present study, values were set at 1 for all the three responses, but giving the resolution higher importance than the analysis time and a specified value >1.5 was set as a minimum resolution value. A value of combined desirability close to 1 indicates that the combination of the different criteria is matched in a global optimum (30) . It was concluded that there were a set of coordinates, producing high desirability value (0.962), with the SDS (A) of 5.2, buffer molarity 17 mM (B), temperature 25°C (C) and voltage 12 kV (D). The predicted response values were Rs 1 1.88, Rs 2 3.79 and analysis time of ∼8 min.
The developed and optimized method was subjected to method validation according to the ICH guidelines (39) . Validation of the method in terms of linearity, precision, accuracy, specificity, robustness, LOD and LOQ was assessed. The LOD of HCT impurity was calculated using signal-to-noise ratio and was found to be 2.5 µg/mL. System suitability was assessed by multiple injections of standard substances, and the obtained RSD% indicates good performance of the system. The obtained results by the determination of HCT, IRB in Kansartan Plus ® tablets and HCT and BISO in Lodoz ® tablets indicate that the method could be successfully applied in quality control laboratories. Standard and sample solution stabilities were checked up to 3 days at room temperature, and we measured the responses on one time on each day. No degradation of HCT, IRB and BISO was observed during this period. All the calculated validation parameters indicate that the developed and optimized method was suitable, linear, precise and accurate for the simultaneous determination of HCT, IRB and BISO in bulk and pharmaceutical dosage forms. The applied method was comparable with the official method (1) for the determination of the studied drugs in their pure forms, where there is no significant difference with respect to both accuracy and precision.
Conclusion
MECK coupled with chemometric tools can provide a complete profile of a separation process and is considered highly powerful, providing useful information of separation and factor interactions. The obtained models demonstrate a significant influence of the studied factors on resolution and analysis time. Optimal conditions were obtained by applying Derringer's desirability function based on defining a global desirability according to the specified constraints. The optimized MEKC method was applied to the quantitative analysis of different dosage forms, with good analytical parameters and relatively short analysis time. It can be concluded that the developed and optimized method was accurate, specific, suitable and precise for the determination of HCT, IRB and BISO in quality control laboratories. The figures in parenthesis are the corresponding theoretical values at P = 0.05.
a Average of at least three experiments.
